Developing hormone receptor-based medicines, for lif
A clinical trial evaluating an oral medicine to potentially treat stress urinary incontinence (SUI)
Our lead product candidate is focused on stress urinary incontinence, which affects up to 35 percent of adult women. Learn about our pipeline »